IP Library Granted Patent US 7,091,038
Granted Patent B2
US 7,091,038 · App. 09/965,703 · Granted Aug 15, 2006

Ecdysone receptor-based inducible gene expression system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,091,038
App. No.
09/965,703
Granted
Aug 15, 2006
Kind
B2
Abstract

This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screetng assays, functional genomics and regulation of traits in transgenic plants and animals.

Claims (37)

1. A gene expression modulation system comprising:

a) a first gene expression cassette that is capable of being expressed in a host cell comprising a polynucleotide encoding a first polypeptide comprising:

i) a DNA-binding domain that recognizes a response element associated with a gene whose expression is to be modulated;

ii) a ligand binding domain comprising a ligand binding domain from a nuclear receptor,

b) a second gene expression cassette that is capable of being expressed in the host cell comprising a polynucleotide encoding a second polypeptide comprising:

i) a transactivation domain; and

ii) a ligand binding domain comprising a ligand binding domain from a nuclear receptor other than ultraspiracle (USP), wherein the ligand binding domains from the first polypeptide and the second polypeptide are different.

2. The gene expression modulation system according to claim 1 , further comprising a third gene expression cassette comprising:

i) a response element to which the DNA-binding domain of the first polypeptide binds;

ii) a promoter that is activated by the transactivation domain of the second polypeptide; and

iii) the gene whose expression is to be modulated.

3. The gene expression modulation system according to claim 1 , wherein the ligand binding domain of the first polypeptide is an ecdysone receptor polypeptide.

4. The gene expression modulation system according to claim 1 , wherein the ligand binding domain of the second polypeptide is a retinoid X receptor polypeptide.

5. A gene expression modulation system comprising:

a) a first gene expression cassette that is capable of being expressed in a host cell comprising a polynucleotide encoding a first polypeptide comprising:

i) a DNA-binding domain that recognizes a response element associated with a gene whose expression is to be modulated; and

ii) a ligand binding domain comprising a ligand binding domain from an ecdysone receptor; and

b) a second gene expression cassette that is capable of being expressed in the host cell comprising a polynucleotide encoding a second polypeptide comprising:

i) a transactivation domain; and

ii) a ligand binding domain comprising a ligand binding domain from a retinoid X receptor.

6. The gene expression modulation system according to claim 5 , further comprising a third gene expression cassette comprising:

i) a response element to which the DNA-binding domain of the first polypeptide binds;

ii) a promoter that is activated by the transactivation domain of the second polypeptide; and

iii) the gene whose expression is to be modulated.

7. The gene expression modulation system according to claim 5 , wherein the ligand binding domain of the first polypeoptide is encoded by a polynucleotide comprising the nucleic acid sequence of SEQ ID NO:3.

8. A gene expression modulation system comprising:

a) a first gene expression cassette that is capable of being expressed in a host cell comprising a polynucleotide encoding a first polypeptide comprising:

i) a DNA-binding domain that recognizes a response element associated with a gene whose expression is to be modulated; and

ii) a ligand binding domain comprising a ligand binding domain from a retinoid X receptor, and

b) a second gene expression cassette that is capable of being expressed in the host cell comprising a polynucleotide encoding a second polypeptide comprising:

i) a transactivation domain; and

ii) a ligand binding domain comprising a ligand binding domain from an ecdysone receptor.

9. The gene expression modulation system according to claim 8 , further comprising a third gene expression cassette comprising:

i) a response element to which the DNA-binding domain of the first polypeptide binds;

ii) a promoter that is activated by the transactivation domain of the second polypeptide; and

iii) the gene whose expression is to be modulated.

10. The gene expression modulation system according to claim 8 , wherein the ligand binding domain of the second polypeptide is encoded by a polynucleotide comprising the nucleic acid sequence of SEQ ID NO:3.

Assignments (9)
MERGER Recorded Mar 31, 2009
From: RHEOGENE HOLDINGS, INC.
To: RHEOGENE, INC. (DE CORPORATION)
Reel/Frame 022473/0642 →
MERGER Recorded Mar 30, 2007
From: RHEOGENE, INC.
To: INTREXON CORPORATION
Reel/Frame 019084/0469 →
MERGER Recorded Mar 30, 2007
From: RHEOGENE, INC.
To: RHEOGENE, INC. (A DELAWARE CORPORATION)
Reel/Frame 019084/0392 →
LICENSE Recorded Mar 29, 2007
From: RHEOGENE HOLDINGS, INC.
To: RHEOGENE, INC.
Reel/Frame 019084/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2007
From: NEW RHEOGENE I, LLC
To: UNIVERSITY OF PITTSBURGH MEDICAL CENTER
Reel/Frame 019077/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2007
From: UNIVERSITY OF PITTSBURGH MEDICAL CENTER
To: RHEOGENE HOLDINGS, INC.
Reel/Frame 019077/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2007
From: PALLI, SUBBA REDDY; KAPITSKAYA, MARIANA ZINOVJEVNA; KUMAR, MOHAN BASAVARAJU; CRESS, DEAN ERVIN
To: ROHM AND HAAS COMPANY
Reel/Frame 019069/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2004
From: RGH LLC
To: NEW RHEOGENE I LLC
Reel/Frame 015177/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2004
From: ROHM AND HAAS COMPANY
To: RGH LLC
Reel/Frame 014394/0528 →